TY - JOUR
T1 - De novo variants in MED12 cause X-linked syndromic neurodevelopmental disorders in 18 females
AU - Polla, D. L.
AU - Bhoj, E. J.
AU - Verheij, J. B. G. M.
AU - Wassink-Ruiter, J. S. Klein
AU - Reis, A.
AU - Deshpande, C.
AU - Gregor, A.
AU - Hill-Karfe, K.
AU - Vulto-van Silfhout, A. T.
AU - Pfundt, R.
AU - Bongers, E. M. H. F.
AU - Hakonarson, H.
AU - Berland, S.
AU - Gradek, G.
AU - Banka, S.
AU - Chandler, K.
AU - Gompertz, L.
AU - Huffels, S. C.
AU - Stumpel, C. T. R. M.
AU - Wennekes, R.
AU - Stegmann, A. P. A.
AU - Reardon, W.
AU - Leenders, E. K. S. M.
AU - de Vries, B. B. A.
AU - Li, D.
AU - Zackai, E.
AU - Ragge, N.
AU - Lynch, S. A.
AU - Cuddapah, S.
AU - van Bokhoven, H.
AU - Zweier, C.
AU - de Brouwer, A. P. M.
N1 - Funding Information:
We are grateful to the patients and their families for their participation. This work was supported by the European Union’s Seventh Framework Program (Gencodys; grant 241995 to H.v.B). D.L.P. is recipient of a CAPES Fellowship (99999.013311/2013–01). C.Z. was supported by grants from the German Research Foundation (DFG) (ZW184/ 3–1, ZW184/6–1 and 270949263/GRK2162) and by the IZKF Erlangen (E31). B.B.A.d.V was supported from the Dutch Organization for Health Research and Development (ZON-MW grants 917–86–319 and 912–12–109). C.T.R.M.S. and A.P.A.S. are supported by the European Reference Network (ERN) ITHACA (project ID no 739543). The 100,000 Genomes Project is funded by the National Institute of Health Research and NHS England. The Wellcome Trust, Cancer Research UK, and the Medical Research Council have also funded research structure. This study makes use of data generated by the Genomics England Research Consortium, Deciphering Developmental Disorders (DDD) study, and the DECIPHER community. A full list of centers that contributed to the generation of the data is available from https://decipher.sanger.ac. uk and via email from [email protected]. Funding for the project was provided by Wellcome Trust.
Publisher Copyright:
© 2020, American College of Medical Genetics and Genomics.
PY - 2021/4
Y1 - 2021/4
N2 - Purpose MED12 is a subunit of the Mediator multiprotein complex with a central role in RNA polymerase II transcription and regulation of cell growth, development, and differentiation. This might underlie the variable phenotypes in males carrying missense variants in MED12, including X-linked recessive Ohdo, Lujan, and FG syndromes. Methods By international matchmaking we assembled variant and clinical data on 18 females presenting with variable neurodevelopmental disorders (NDDs) and harboring de novo variants in MED12. Results Five nonsense variants clustered in the C-terminal region, two splice variants were found in the same exon 8 splice acceptor site, and 11 missense variants were distributed over the gene/protein. Protein truncating variants were associated with a severe, syndromic phenotype consisting of intellectual disability (ID), facial dysmorphism, short stature, skeletal abnormalities, feeding difficulties, and variable other abnormalities. De novo missense variants were associated with a less specific, but homogeneous phenotype including severe ID, autistic features, limited speech and variable other anomalies, overlapping both with females with truncating variants as well as males with missense variants. Conclusion We establish de novo truncating variants in MED12 as causative for a distinct NDD and de novo missense variants as causative for a severe, less specific NDD in females.
AB - Purpose MED12 is a subunit of the Mediator multiprotein complex with a central role in RNA polymerase II transcription and regulation of cell growth, development, and differentiation. This might underlie the variable phenotypes in males carrying missense variants in MED12, including X-linked recessive Ohdo, Lujan, and FG syndromes. Methods By international matchmaking we assembled variant and clinical data on 18 females presenting with variable neurodevelopmental disorders (NDDs) and harboring de novo variants in MED12. Results Five nonsense variants clustered in the C-terminal region, two splice variants were found in the same exon 8 splice acceptor site, and 11 missense variants were distributed over the gene/protein. Protein truncating variants were associated with a severe, syndromic phenotype consisting of intellectual disability (ID), facial dysmorphism, short stature, skeletal abnormalities, feeding difficulties, and variable other abnormalities. De novo missense variants were associated with a less specific, but homogeneous phenotype including severe ID, autistic features, limited speech and variable other anomalies, overlapping both with females with truncating variants as well as males with missense variants. Conclusion We establish de novo truncating variants in MED12 as causative for a distinct NDD and de novo missense variants as causative for a severe, less specific NDD in females.
KW - BLEPHAROPHIMOSIS
KW - DELINEATION
KW - FG SYNDROME
KW - GENE
KW - MEDIATOR COMPLEX
KW - MENTAL-RETARDATION
KW - MUTATION
KW - OHDO SYNDROME
KW - PHENOTYPE
KW - TRANSCRIPTION
U2 - 10.1038/s41436-020-01040-6
DO - 10.1038/s41436-020-01040-6
M3 - Article
C2 - 33244165
SN - 1098-3600
VL - 23
SP - 645
EP - 652
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 4
ER -